{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:41Z","timestamp":1772166281773,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01 DE028563"],"award-info":[{"award-number":["R01 DE028563"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Image guidance in radiation oncology has resulted in significant improvements in the accuracy and precision of radiation therapy (RT). Recently, the resolution and quality of cone beam computed tomography (CBCT) for image guidance has increased so that tumor masses and lymph nodes are readily detectable and measurable. During treatment of head and neck squamous cell carcinoma (HNSCC), on-board CBCT setup imaging is routinely obtained; however, this CBCT imaging data is not utilized to predict patient outcomes. Here, we analyzed whether changes in CBCT measurements obtained\n                      <jats:italic>during<\/jats:italic>\n                      a course of radiation therapy correlate with responses on routine 3-month follow-up diagnostic imaging and overall survival (OS).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials\/methods<\/jats:title>\n                    <jats:p>Patients with oropharyngeal primary tumors who received radiation therapy between 2015 and 2018 were included. Anatomical measurements were collected of largest nodal conglomerate (LNC) at CT simulation, end of radiation treatment (EOT CBCT), and routine 3-month post-RT imaging. At each timepoint anteroposterior (AP), mediolateral (ML) and craniocaudal (CC) measurements were obtained and used to create a 2-dimensional (2D) maximum.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CBCT data from 64 node positive patients were analyzed. The largest nodal 2D maximum and CC measurements on EOT CBCT showed a statistically significant correlation with complete response on 3-month post-RT imaging (r\u2009=\u20090.313, p\u2009=\u20090.02 and r\u2009=\u20090.318, p\u2009=\u20090.02, respectively). Furthermore, patients who experienced a 30% or greater reduction in the CC dimension had improved OS (Binary Chi-Square HR 4.85, p\u2009=\u20090.028).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Decreased size of pathologic lymph nodes measured using CBCT setup imaging during a radiation course correlates with long term therapeutic response and overall survival of HNSCC patients. These results indicate that CBCT setup imaging may have utility as an early predictor of treatment response in oropharyngeal HNSCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-021-01871-w","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T04:03:24Z","timestamp":1628481804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma"],"prefix":"10.1186","volume":"16","author":[{"given":"Whitney","family":"Sumner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangwoo S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Vitzthum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Atwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayuri","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Califano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren K.","family":"Mell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arno J.","family":"Mundt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2075-1197","authenticated-orcid":false,"given":"Andrew B.","family":"Sharabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"issue":"1","key":"1871_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"R Siegel","year":"2018","unstructured":"Siegel R, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2018;68(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"1871_CR2","unstructured":"National Comprehensive Cancer Network. Head and Neck Cancers (Version 1.2019). 2019 06\/10\/2020]; https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf."},{"issue":"4","key":"1871_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3322\/caac.21349","volume":"66","author":"K Miller","year":"2016","unstructured":"Miller K, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2016;66(4):271\u201389.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"1871_CR4","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1634\/theoncologist.2009-0289","volume":"15","author":"D Pulte","year":"2010","unstructured":"Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 2010;15(9):994\u20131001.","journal-title":"Oncologist"},{"key":"1871_CR5","unstructured":"Wang A, Paysan P, Brehm M, et al. Advanced scatter correction and iterative reconstruction for improved cone-beam CT imaging on the TrueBeam radiotherapy machine Association of Physicists in Medicine. Annual Meeting. 2016."},{"key":"1871_CR6","doi-asserted-by":"publisher","first-page":"S491","DOI":"10.1016\/S0167-8140(17)31330-0","volume":"123","author":"I Chetty","year":"2017","unstructured":"Chetty I, Paysan P, Siddiqui F, et al. Improving CBCT image quality for daily image guidance of patients with head\/neck and prostate cancer. Radiother Oncol. 2017;123:S491-492.","journal-title":"Radiother Oncol"},{"issue":"2","key":"1871_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.adro.2018.12.003","volume":"4","author":"S Gardner","year":"2019","unstructured":"Gardner S, Mao W, Liu C, et al. Improvements in CBCT image quality using a novel iterative reconstruction algorithm: a clinical evaluation. Adv Radiat Oncol. 2019;4(2):390\u2013400.","journal-title":"Adv Radiat Oncol"},{"key":"1871_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.ijrobp.2003.12.024","volume":"59","author":"J Barker","year":"2004","unstructured":"Barker J, Garden AS, Ang KK, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT\/linear accelerator system. Int J Radiat Oncol Biol Phys. 2004;59:960\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1871_CR9","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/hed.21981","volume":"34","author":"G Sanguineti","year":"2012","unstructured":"Sanguineti G, Ricchetti F, Wu B, et al. Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapy. Head Neck. 2012;34:1640\u20137.","journal-title":"Head Neck"},{"issue":"4","key":"1871_CR10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.ijrobp.2018.06.048","volume":"102","author":"B Rosen","year":"2018","unstructured":"Rosen B, Hawkins PG, Polan DF, et al. Early changes in serial CBCT-measured parotid gland biomarkers predict chronic xerostomia after head and neck radiation therapy. Int J Radiat Oncol Biol Phys. 2018;102(4):1319\u201329.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1871_CR11","doi-asserted-by":"publisher","first-page":"S420","DOI":"10.1016\/j.ijrobp.2007.07.1565","volume":"69","author":"D Hwang","year":"2007","unstructured":"Hwang D, Vakilha M, Breen S, et al. Temporo-spatial changes of enlarged cervical lymph nodes during head and neck cancer IMRT imaged with daily on-line cone-beam CT. Int J Radiat Oncol Biol Phys. 2007;69(3):S420-421.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1871_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7785\/tcrt.2012.500403","volume":"14","author":"J Hou","year":"2015","unstructured":"Hou J, Guerrero M, Suntharalingam M, et al. Response assessment in locally advanced head and neck cancer based on RECIST and volume measurements using cone beam CT images. Tech Canc Res Treatm. 2015;14(1):19\u201327.","journal-title":"Tech Canc Res Treatm"},{"issue":"3","key":"1871_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ijrobp.2014.11.002","volume":"91","author":"C Anderson","year":"2015","unstructured":"Anderson C, Change T, Graham MM, et al. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography\/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Int J Radiat Oncol Biol Phys. 2015;91(3):472\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1871_CR14","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0360-3016(03)00757-0","volume":"57","author":"I Koike","year":"2003","unstructured":"Koike I, Ohmura M, Hata M, et al. FDG-PET scanning after radiation can predict tumor regrowth three months later. Int J Radiat Oncol Biol Phys. 2003;57:1231\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1871_CR15","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s002590100537","volume":"28","author":"K Kubota","year":"2001","unstructured":"Kubota K, Itoh M, Ozaki K, et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med. 2001;28:696\u2013703.","journal-title":"Eur J Nucl Med"},{"key":"1871_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijrobp.2008.07.019","volume":"74","author":"M Yao","year":"2009","unstructured":"Yao M, Smith RB, Hoffman HT, et al. Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer\u2014a long-term outcome report. Int J Radiat Oncol Biol Phys. 2009;74:9\u201314.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1871_CR17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2967\/jnumed.118.217976","volume":"60","author":"M Rohde","year":"2019","unstructured":"Rohde M, Nielsen AL, Pareek M, et al. PET\/CT versus standard imaging for prediction of survival in patients with recurrent head and neck squamous cell carcinoma. J Nucl Med. 2019;60(5):592\u20139.","journal-title":"J Nucl Med"},{"issue":"4","key":"1871_CR18","doi-asserted-by":"publisher","first-page":"e0215465","DOI":"10.1371\/journal.pone.0215465","volume":"14","author":"R Beichel","year":"2019","unstructured":"Beichel R, Ulrich EJ, Smith BJ, et al. FDG PET based prediction of response in head and neck cancer treatment: assessment of new quantitative imaging features. PLoS ONE. 2019;14(4):e0215465.","journal-title":"PLoS ONE"},{"issue":"4","key":"1871_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","volume":"17","author":"M Schemper","year":"1996","unstructured":"Schemper M, Smith TL. A note on qualifying follow-up studies in the failure time. Control Clin Trials. 1996;17(4):343\u20136.","journal-title":"Control Clin Trials"},{"issue":"12","key":"1871_CR20","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1002\/lary.24826","volume":"124","author":"S Chen","year":"2014","unstructured":"Chen S, Hsieh T, Yen KY, et al. Interim FDG PET\/CT for predicting the outcome in patients with head and neck cancer. Laryngoscope. 2014;124(12):2732\u20138.","journal-title":"Laryngoscope"},{"issue":"6","key":"1871_CR21","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00259-018-3978-3","volume":"45","author":"N Helsen","year":"2018","unstructured":"Helsen N, Van den Wyngaert T, Carp L, et al. FDG- PET\/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance. Eur J Nucl Med Mol Imaging. 2018;45(6):1063\u201371.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"17","key":"1871_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21170","volume":"21","author":"H Mehanna","year":"2017","unstructured":"Mehanna H, McConkey CC, Rahman JK, et al. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2\/N3) nodal metastases in patients with squamous cell head and neck cancer. Health Technol Assess. 2017;21(17):1\u2013122.","journal-title":"Health Technol Assess"},{"key":"1871_CR23","unstructured":"Chemoradiation vs immunotherapy and radiation for head and neck cancer. 2017. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03383094?term=KEYCHAIN&draw=2&rank=1."},{"key":"1871_CR24","unstructured":"A study of Atezolizumab (Anti-Pd-L1 Antibody) as adjuvant therapy after definitive local therapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck. 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03452137."},{"key":"1871_CR25","unstructured":"Stereotactic body radiation therapy and Durvalumab with or without Tremelimumab before surgery in treating participants with human papillomavirus positive oropharyngeal squamous cell cancer. 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03618134."},{"issue":"1","key":"1871_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"K Ang","year":"2010","unstructured":"Ang K, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24\u201335.","journal-title":"N Engl J Med"},{"issue":"18","key":"1871_CR27","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1158\/1078-0432.CCR-16-0323","volume":"22","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Koneva LA, Virani S, et al. Subtypes of HPV-positive head and neck cancers are associated with HPV characteristics, copy number alterations, PIK3CA mutation, and pathway signatures. Clin Cancer Res. 2016;22(18):4735\u201345.","journal-title":"Clin Cancer Res"},{"key":"1871_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.oraloncology.2018.08.009","volume":"85","author":"DJ Lee","year":"2018","unstructured":"Lee DJ, et al. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes. Oral Oncol. 2018;85:44\u201351.","journal-title":"Oral Oncol"},{"issue":"4","key":"1871_CR29","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1158\/1078-0432.CCR-14-2481","volume":"21","author":"MK Keck","year":"2015","unstructured":"Keck MK, et al. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clin Cancer Res. 2015;21(4):870\u201381.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1871_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1001\/jamaoncol.2016.1790","volume":"3","author":"LGT Morris","year":"2017","unstructured":"Morris LGT, et al. The molecular landscape of recurrent and metastatic head and neck cancers: insights from a precision oncology sequencing platform. JAMA Oncol. 2017;3(2):244\u201355.","journal-title":"JAMA Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01871-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-021-01871-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01871-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T04:21:19Z","timestamp":1628482879000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-021-01871-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1871"],"URL":"https:\/\/doi.org\/10.1186\/s13014-021-01871-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-325758\/v1","asserted-by":"object"}]},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"15 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of California Human Research Protections Program.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare competing financial interests: LKM reports University research funding from Merck, consultant fees from Bayer HealthCare, and other fees from Merck and E.R. Squibb & Sons outside the submitted work. A.B.S. reports University research funding and honoraria from Pfizer and Varian Medical Systems, consultant fees from Astrazeneca, and other fees from Merck. A.B.S. is the scientific founder and has an equity interest in Toragen Inc. outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}